The Center for Communicable Disease Dynamics (CCDD) at Harvard School of Public Health (HSPH) will serve as a national and international center for research, teaching, and outreach to public health decision makers and other stakeholders in infectious disease modeling and epidemiology. The Center will expand and augment thriving training programs in infectious disease epidemiology and health decision science while strengthening connections within Harvard University and the surrounding area to draw in bioinformaticians, biostatisticians, evolutionary biologists, and others to activities related to infectious disease modeling and data analysis. Substantive research will focus on antimicrobial resistance, communicable disease seasonality, and the broad area of policy decisions around the allocation of scarce control measures. We will also develop novel methodology, emphasizing tools for analyzing emerging epidemics and directing control measures to optimize their effectiveness, as well as on the use of genetic and ultimately genome sequence data to track epidemics and to detect the effects of natural selection on pathogen populations. The Center will have numerous activities to make its resources, people, and methods widely available and to maintain productive interactions with public health professionals, decision makers and others. Software, including an epidemic analysis """"""""dashboard,"""""""" will be developed in partnership with public health collaborators from the US and Hong Kong. A short course in infectious disease modeling will be designed and offered annually at rotating sites on several continents;materials for this course and for a novel course on infectious disease statistics (to be developed at HSPH) will be made available by web. An annual symposium on a topic of public health importance will host academic and policymaking experts. Educational activities for science journalists will be set up. Short-term visiting fellowships for CDC and other scientists will be set up to facilitate collaborations, and a semester sabbatical for a faculty member from a minority serving institution (MSI) will be set up. Additional activities for outreach to disadvantaged group members will occur, including an """"""""ambassador"""""""" program and funded masters studentships with matching university funds. Intensive efforts will be made to integrate research, outreach, and teaching functions.
Infectious disease modeling is an increasingly important part of decision making about the use and funding of interventions to control the spread of diseases. This Center will meet needs for enhanced training of modelers, better communication between modelers and policymakers, better methods and software for infectious disease data analysis, and enhanced understanding of key questions in infectious disease dynamics.
|Cobey, Sarah; Baskerville, Edward B; Colijn, Caroline et al. (2017) Host population structure and treatment frequency maintain balancing selection on drug resistance. J R Soc Interface 14:|
|Eyal, Nir; Lipsitch, Marc (2017) Vaccine testing for emerging infections: the case for individual randomisation. J Med Ethics 43:625-631|
|Feng, Shuo; Fowlkes, Ashley L; Steffens, Andrea et al. (2017) Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness. Epidemiology 28:514-524|
|Buckee, Caroline O; Tatem, Andrew J; Metcalf, C Jessica E (2017) Seasonal Population Movements and the Surveillance and Control of Infectious Diseases. Trends Parasitol 33:10-20|
|Wesolowski, Amy; Zu Erbach-Schoenberg, Elisabeth; Tatem, Andrew J et al. (2017) Multinational patterns of seasonal asymmetry in human movement influence infectious disease dynamics. Nat Commun 8:2069|
|Halloran, M Elizabeth; Auranen, Kari; Baird, Sarah et al. (2017) Simulations for designing and interpreting intervention trials in infectious diseases. BMC Med 15:223|
|Worby, Colin J; Wallinga, Jacco; Lipsitch, Marc et al. (2017) Population effect of influenza vaccination under co-circulation of non-vaccine variants and the case for a bivalent A/H3N2 vaccine component. Epidemics 19:74-82|
|Kraemer, Moritz U G; Faria, Nuno R; Reiner Jr, Robert C et al. (2017) Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015-16: a modelling study. Lancet Infect Dis 17:330-338|
|Nathavitharana, Ruvandhi R; Shi, Cynthia X; Chindelevitch, Leonid et al. (2017) Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru. Emerg Infect Dis 23:1887-1890|
|Andam, Cheryl P; Worby, Colin J; Gierke, Ryan et al. (2017) Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States. Emerg Infect Dis 23:1012-1015|
Showing the most recent 10 out of 405 publications